A Review of Issues Affecting the Efficiency of Decision Making in the NICE Single Technology Appraisal Process
Tóm tắt
Từ khóa
Tài liệu tham khảo
National Institute for Health and Care Excellence. Guide to the processes of technology appraisal. NICE. 2018. https://www.nice.org.uk/process/pmg19/chapter/acknowledgements . Accessed 1 Jul 2018.
National Institute for Health and Care Excellence. Proposals for increasing capacity within NICE’s technology appraisal programme. NICE. 2017. https://www.nice.org.uk/Media/Default/About/what-we-do/our-programmes/technology-appraisals/increasing-ta-capacity-consultation.pdf . Accessed 21 Dec 2017.
Yan L, Zhang W. Precision medicine becomes reality—tumour type agnostic-therapy. Cancer Commun. 2018;38(6).
National Institute for Health and Care Excellence, NHS England. Consultation on changes to technology appraisals and highly specialised technologies. NHS England. 2017.
Carroll C, Houten R, Boland A, Kaltenthaler E, Dickson R. What is the evidence from past National Institute of Health and Care Excellence Single-Technology Appraisals regarding company submissions with base-case incremental cost-effectiveness ratios of less than £10,000/QALY? Value Health. 2017;21:341–50.
Kaltenthaler E, Carroll C, Hill-McManus D, Scope A, Holmes M, Rice S, Rose M, Tappenden P, Woolacott N. Issues related to the frequency of exploratory analyses by Evidence Review Groups in the NICE Single Technology Appraisal process. PharmacoEconomics Open. 2016;1:99–108.
Cerri KH, Knapp M, Ferández JL. Decision making by NICE: examining the influences of evidence, process and context. Health Econ Policy Law. 2014;9(2):119–41.
Dakin H, Devlin N, Feng Y, Rice N, O’Neill P, Parkin D. The influence of cost-effectiveness and other factors on NICE decisions. Health Econ. 2015;24:1256–71.
National Audit Office. Investigation into the Cancer Drugs Fund: National Audit Office. 2015. https://www.nao.org.uk/wp-content/uploads/2015/09/Investigation-into-the-Cancer-Drugs-Fund1.pdf . Accessed 5 May 2018.
NHS England Cancer Drugs Fund Team. Appraisal and funding of cancer drugs from July 2016 (including the new Cancer Drugs Fund) - a new deal for patients, taxpayers and industry. NHS England. 2016. https://www.england.nhs.uk/wp-content/uploads/2013/04/cdf-sop.pdf . Accessed 20 May 2018.
Akehurst RL, Abadie E, Renaudin N, Sarkozy F. Variation in health technology assessment and reimbursement processes in Europe. Value Health. 2017;20:67–76.